Dr. Halterman is a professor of neurology, senior associate dean for research, and director of the MD-PhD program at the University at the Jacobs School of Medicine and Biomedical Sciences. Dr. Halterman’s clinical and research interests relate to vascular neurology and immunobiology. Dr. Halterman received his BS in Chemistry from Georgetown University and graduated from the University of Rochester with an MD with honors and a Ph.D. from the Department of Microbiology and Immunology. After completing residency training in neurology and a fellowship in experimental therapeutics, Dr. Halterman received a pathway to independence award (K99/R00) from the NIH in 2008. He currently directs the Neurovascular Protection Group, and their work focuses on neurovascular-immune interactions and the development of neurovascular protection in models of cerebrovascular disease. Current studies are focused on investigating novel drug targets to treat stroke, and have ongoing academic-industry collaborations focused on the development of a novel class of tetracyclines to treat acute CNS ischemia. Their work has been supported by funding from the National Institute of Neurological Disease and Stroke (NINDS), the Department of Defense, and the American Heart Association. Dr. Halterman is a fellow of the American Heart Association.